1Pepine CJ,Handberg EM,Cooper-DeHoff RM,et al.A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease.JAMA,2003,290:2805-2816.
2The ALLHAT officers and coordinators for the ALLHAT collaborative research group.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.JAMA,2002,288:2981-2997.
3Juius S,Kjeldsen SE,Weber M,et al.Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amolodipine.Lancet,2004,363:2022-2031.
4Bakris GL,Fonseca V,Katholi RE,et al.Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension.JAMA,2004,292:2227-2236.
5Pool-Wilson PA,Lubsen J,Kirwan BA,et al.Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment.Lancet,2004,364:849-857.
7Nissen S,Tuzcu EM,Libby P,et al.Effect of antihypertensive agents on cardiovascular events in patients with coronary heart disease and normal blood pressure.JAMA,2004,292:2217-2226.
